The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMhp Reg S Regulatory News (MHPC)

Share Price Information for Mhp Reg S (MHPC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.38
Bid: 3.37
Ask: 3.39
Change: 0.02 (0.60%)
Spread: 0.02 (0.593%)
Open: 3.38
High: 3.38
Low: 3.37
Prev. Close: 3.36
MHPC Live PriceLast checked at -
  • This share is an international stock.

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

MHP RELEASES EARLY TENDER AND CONSENT RESULTS

21 Mar 2013 12:14

RNS Number : 5667A
MHP S.A.
21 March 2013
 



IIIA: MHP RELEASES EARLY TENDER AND CONSENT RESULTS VIA JPM, MS AND VTB

 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL TO DISTRIBUTE THIS ANNOUNCEMENT, AS MORE FULLY DESCRIBED IN THE TENDER OFFER AND CONSENT SOLICITATION STATEMENT.

 

21 March 2013 - MHP S.A. (the "Company") announces today the early results of its previously announced cash tender offer (the "Tender Offer") for its outstanding USD584,767,000 10.25% Notes due 2015 (the "Notes"), and related solicitation (the "Consent Solicitation") of consents (the "Consents") to certain proposed amendments (the "Proposed Amendments") to the indenture dated April 29, 2010 (the "Indenture") under which the Notes were issued, as set forth in the tender and consent solicitation statement dated March 6, 2013 (the "Statement"). The Tender Offer is conditional, among other conditions, upon the New Issue Condition.

As of 5:00 p.m., New York time, on March 20, 2013 (the "Early Tender Date" and the "Consent Expiration Date"), the Company has received valid tenders of USD463,298,000 in aggregate principal amount of Notes representing approximately 79% of the outstanding Notes.

Based on the receipt of Consents from holders of a majority in aggregate principal amount of Notes outstanding, the Company intends to enter into the supplemental indenture (the "Supplemental Indenture") with the trustee to adopt the Proposed Amendments. The effectiveness of the Proposed Amendments is subject to the conditions that (i) the Company in its good faith judgement believes that the New Issue Condition will be satisfied and, therefore, that it believes that it will be able to consummate the Tender Offer and (ii) the Consent Settlement Date has occurred.

The Tender Offer will expire at 11:59 p.m., New York time, on April 4, 2013, unless extended or earlier terminated by the Company (the "Tender Expiration Date").

Holders who have validly tendered and not withdrawn Notes on or prior to the Early Tender Date will be eligible to receive the Early Tender Offer Consideration of $1,095 for each $1,000 principal amount and the Consent Payment of $5 for each $1,000 principal amount. Holders validly tendering and not withdrawing Notes after the Early Tender Date but on or prior to the Tender Expiration Date will only be eligible to receive the Tender Offer Consideration of $1,045 for each $1,000 principal amount. Holders who have validly delivered and not revoked their Consent on or prior to the Consent Expiration Date shall be eligible to receive the Consent Payment on the Consent Settlement Date, whether or not they also elect to tender the Notes in respect of which such Consent are delivered.

The complete terms and conditions of the Tender Offer and the Consent Solicitation are described in the Statement. Copies of the Statement are available from the Information and Tender Agent, which can be contacted at the e-mail address and telephone number set out below. Holders may also contact the Dealer Manager at the e-mail address and telephone number set out below for information concerning the Tender Offer and the Consent Solicitation. Holders may also contact their broker, dealer, commercial bank or trust company or other nominee for assistance concerning the Tender Offer and the Consent Solicitation.

Capitalized terms used and not defined herein shall have the meaning set forth in the Statement.

 

 

Dealer Managers:

J.P. Morgan (+44 20 7134 1366/+44 20 7134 3414, emea_lm@jpmorgan.com)

Morgan Stanley (+44 20 7677 7799/ liabilitymanagementeurope@morganstanley.com)

VTB Capital (+44 203 334 8029 / vtb.dcm@vtbcapital.com)

Requests for information in relation to the Tender Offer should be directed to the

 

Information and Tender Agent:

D.F. King (Banks and Brokers Call: (212) 269 5550 / All others call toll free: (800) 967 4612 / London contact +44 20 7920 9700, mhp@dfking.com)

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCSEDFEFFDSEFD
Date   Source Headline
2nd May 20247:30 amRNS2023 Integrated Annual Report and Press Statement
11th Mar 20241:02 pmRNSEGM Results
7th Feb 202412:41 pmRNSEGM- Convening Notice
23rd Jan 20249:54 amRNSAppointment of a new ARC Chair
16th Nov 20237:13 amRNSQ3 and 9M 2023 Financial Results
25th Sep 20239:02 amRNSFinancial Statement Q2 2023
21st Sep 20237:06 amRNSDate Notification Q2 2023 Results
8th Sep 20237:00 amRNSMHP SE Invests in Saudi Arabia
19th Jun 20238:41 amRNSAGM results
18th May 20237:00 amRNSQ1 2023 Financial and Operational Results
17th May 202311:00 amRNSAGM Convening Notice
11th Apr 20239:42 amRNSMHP SE Standalone FS 2022
11th Apr 20239:27 amRNSMHP SE Standalone FS 2022
11th Apr 20238:54 amRNSMHP SE Standalone 2022
11th Apr 20237:00 amRNS2022 Integrated Annual Report
21st Mar 202311:07 amRNSDate Notification - Date Change
7th Mar 202310:24 amRNSEGM results
16th Feb 20231:54 pmRNSMHP and Tanmiah - announcement of a partnership
2nd Feb 20237:25 amRNSConvening Notice - EGM
25th Jan 20237:53 amRNSMonthly Operational Update - December 2022
17th Jan 20234:41 pmRNSSecond Price Monitoring Extn
17th Jan 20234:35 pmRNSPrice Monitoring Extension
23rd Dec 20227:00 amRNSMonthly Operational Update - November 2022
25th Nov 20228:00 amRNSMonthly Operational Update - October 2022
16th Nov 20227:00 amRNSQ3 and 9M 2022 Financial and Operational Results
25th Oct 20227:00 amRNSMonthly Operational Update - September
23rd Sep 20227:19 amRNSOperational Monthly Update - August 2022
14th Sep 20227:00 amRNSQ2 and H1 2022 Financial Results
2nd Sep 202212:40 pmRNSDate Change Notification
19th Aug 202210:20 amRNSOperational Monthly Update - July 2022
9th Aug 20224:41 pmRNSSecond Price Monitoring Extn
9th Aug 20224:36 pmRNSPrice Monitoring Extension
27th Jul 20227:13 amRNSQ2 and H1 2022 Pre close trading update
22nd Jul 20227:21 amRNSOperational Monthly Update - June 2022
30th Jun 20222:22 pmRNS2021 MHP Sustainability Report
24th Jun 20227:27 amRNSMHP Monthly Update - May 2022
17th Jun 20227:56 amRNSQ1 2022 Financial Results
24th May 20227:44 amRNSMonthly Operational Update for April 2022
17th May 202212:25 pmRNSAGM - Convening Notice
5th May 202212:06 pmRNSSeparate FS
5th May 202210:57 amRNSFinancial Results for the Q4 and 12M 2021
28th Apr 202210:16 amRNSDate notification
22nd Apr 20229:43 amRNSPre-Close TU for the Q1 2022
11th Apr 202210:48 amRNSMHP - Operational Update
30th Mar 20223:55 pmRNSConsent Solicitation - Results Announcement
23rd Mar 20221:40 pmRNSUpdate Announcement - Consent Solicitation
21st Mar 202210:49 amRNSMHP - Consent Solicitation Announcement
18th Mar 20221:57 pmRNSCoupon Payment Information
14th Mar 20229:41 amRNSDamage to Warehouse - Loss of Produce
10th Mar 20228:26 amRNSMHP - SUPPORT FOR UKRAINE

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.